N-[2-Hydroxy-5-(1-hydroxy-2-{1-[4-(2-imino-5-oxo-imidazolidin-4-ylidenemethyl)-phenyl]-piperidin-4-ylamino}-ethyl)-phenyl]-methanesulfonamide

ID: ALA174054

Chembl Id: CHEMBL174054

PubChem CID: 135995976

Max Phase: Preclinical

Molecular Formula: C24H30N6O5S

Molecular Weight: 514.61

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CS(=O)(=O)Nc1cc(C(O)CNC2CCN(c3ccc(/C=C4\N=C(N)NC4=O)cc3)CC2)ccc1O

Standard InChI:  InChI=1S/C24H30N6O5S/c1-36(34,35)29-19-13-16(4-7-21(19)31)22(32)14-26-17-8-10-30(11-9-17)18-5-2-15(3-6-18)12-20-23(33)28-24(25)27-20/h2-7,12-13,17,22,26,29,31-32H,8-11,14H2,1H3,(H3,25,27,28,33)/b20-12-

Standard InChI Key:  ZESZFZAGJRRLFK-NDENLUEZSA-N

Alternative Forms

  1. Parent:

    ALA174054

    ---

Associated Targets(Human)

ADRB3 Tclin Beta-3 adrenergic receptor (5850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor and beta-3 adrenergic receptor (173 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Adrenergic receptor beta; ADRB1 & ADRB3 (200 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 514.61Molecular Weight (Monoisotopic): 514.1998AlogP: 0.84#Rotatable Bonds: 8
Polar Surface Area: 169.38Molecular Species: BASEHBA: 9HBD: 6
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 7.85CX Basic pKa: 9.47CX LogP: -0.99CX LogD: -1.26
Aromatic Rings: 2Heavy Atoms: 36QED Weighted: 0.22Np Likeness Score: -0.78

References

1. Hu B, Malamas M, Ellingboe J, Largis E, Han S, Mulvey R, Tillett J..  (2001)  New oxadiazolidinedione derivatives as potent and selective human beta3 agonists.,  11  (8): [PMID:11327605] [10.1016/s0960-894x(01)00147-0]

Source